Aidapak Recalls Cranberry Extract Capsules Due to Label Mixup
Aidapak Services is recalling Cranberry Extract/Vitamin C capsules because they may be mislabeled as other medications. The products were distributed in four western states.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 2/5 (Moderate).
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II and involves a labeling error (label mixup) without reported illnesses or injuries, fitting the criteria for moderate severity.
Plain-English summary
Aidapak Services, LLC is recalling 546-capsule bottles of Cranberry Extract/Vitamin C Capsule, 450 mg/125 mg, Over The Counter. The recall is due to a labeling error where the product may be mislabeled as other drugs, including Multivitamin/Multimineral, Modafinil, Niacin ER, or Glucosamine/Chondroitin.
The affected products were distributed in Arizona, California, Oregon, and Washington. Specific pedigree codes and expiration dates are listed in the official recall notice.
Consumers should check their medication labels and stop using the product if it matches the description. They should contact their pharmacist or the recalling firm for instructions on returning the product.
The recalled product
- Product
- CRANBERRY EXTRACT/VITAMIN C Capsule, 450 mg/125 mg, Over The Counter, Distributed by: AidaPak Service, LLC, NDC 31604014271
- Manufacturer
- Aidapak Services, LLC
- Hazard
- Affected units
- 546
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (11)
- CRANBERRY EXTRACT/VITAMIN C Capsule
- 450 mg/125 mg has the following codes Pedigree: W002692
- EXP: 6/5/2014
- Pedigree: W003715
- EXP: 6/26/2014
- Pedigree: W003716
- Pedigree: AD60240_11
- EXP: 5/22/2014
- Pedigree: W002693
- Pedigree: AD46257_13
- EXP: 5/15/2014.
Distribution
Part of a larger recall action
This product is one of 273 recalled by Aidapak Services, LLC under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 273 products in this recall →Related recalls
Same manufacturer · Aidapak Services, LLC
See all →- ModerateAidapak Recalls Sennosides Tablets Due to Potential Labeling Errors
FDA (Drugs) · 2014-01-29
- ModerateLevothyroxine Sodium Tablets Recalled for Potential Labeling Mixup
FDA (Drugs) · 2014-01-29
- ModerateAidapak Recalls Mislabeled Pantoprazole Sodium DR Tablets
FDA (Drugs) · 2014-01-29
- ModerateAidapak Recalls Nifedipine ER Tablets Due to Potential Label Mixup
FDA (Drugs) · 2014-01-29
- ModerateSimvastatin Tablets Recalled for Potential Labeling Error
FDA (Drugs) · 2014-01-29
Same hazard · mis labeling
See all →- SevereWhite Vein Advanced Alkaloids Chewable Tablets Recall for Excess Active Ingredient
FDA (Food) · 2026-10-14
- SevereBetter Bakehouse Recalls Donutful Chocolate Dipped Vanilla Cake Donuts for Undeclared Milk
FDA (Food) · 2026-10-14
- HighFreshPoint Recalls Cranberry Chicken Salad Wedges for Undeclared Egg Allergen
FDA (Food) · 2026-10-14
- HighJ K Patisserie & Bakery LLC Recalls Croissants for Undeclared Egg
FDA (Food) · 2026-10-14
- LowMindray ePM Series Patient Monitor Manuals Recalled for Alarm Clarification
FDA (Devices) · 2026-10-14
Similar recalls
- ModerateAidapak Recalls Vitamin B Complex Tablets Due to Labeling Mixup
FDA (Drugs) · 2014-01-29
- ModerateAidapak Recalls Cyanocobalamin Tablets Due to Potential Labeling Errors
FDA (Drugs) · 2014-01-29
- ModerateFDA Recalls Vitamin B Complex Capsules Due to Labeling Error
FDA (Drugs) · 2014-01-29
- ModerateAidapak Recalls Niacin ER Tablets Due to Potential Label Mixup
FDA (Drugs) · 2014-01-29
- HighAidapak Recalls Amantadine HCL Capsules Due to Labeling Mixup
FDA (Drugs) · 2014-01-29
- SevereFDA Recalls Vitamin B Complex Tablets Due to Potential Label Mixup
FDA (Drugs) · 2014-01-29